I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Juan Jaen Biography and Net Worth

President of Arcus Biosciences

Dr. Jaen has been engaged in all aspects of drug discovery and development for more than 30 years, and in 2015 he co-founded Arcus. Before starting Arcus, Dr. Jaen was co-founder and President of Flexus Biosciences. He was Chief Scientific Officer and SVP of Drug Discovery at ChemoCentryx for 7 years, where he led the discovery and progression into the clinic of 8 novel immunology drug candidates. Dr. Jaen has also held various positions at Amgen, Tularik, and Parke-Davis/Warner-Lambert. He is an inventor on 50 patents and has helped the advancement of over 20 novel molecules into clinical development across a range of indications.

What is Juan C. Jaen's net worth?: The estimated net worth of Juan C. Jaen is at least $17.81 million as of February 26th, 2024. Dr. Jaen owns 1,211,365 shares of Arcus Biosciences stock worth more than $17,807,066 as of November 23rd. This net worth approximation does not reflect any other assets that Dr. Jaen may own. Additionally, Dr. Jaen receives a salary of $931,140.00 as President at Arcus Biosciences. Learn More about Juan C. Jaen's net worth.
How old is Juan C. Jaen?: Dr. Jaen is currently 66 years old. There are 6 older executives and no younger executives at Arcus Biosciences. Learn More on Juan C. Jaen's age.
What is Juan C. Jaen's salary?: As the President of Arcus Biosciences, Inc., Dr. Jaen earns $931,140.00 per year. Learn More on Juan C. Jaen's salary.
How do I contact Juan C. Jaen?: The corporate mailing address for Dr. Jaen and other Arcus Biosciences executives is 3928 Point Eden Way, Hayward CA, 94545. Arcus Biosciences can also be reached via phone at (510) 694-6200 and via email at [email protected]. Learn More on Juan C. Jaen's contact information.
Has Juan C. Jaen been buying or selling shares of Arcus Biosciences?: Juan C. Jaen has not been actively trading shares of Arcus Biosciences during the last quarter. Most recently, Juan C. Jaen sold 3,900 shares of the business's stock in a transaction on Monday, February 26th. The shares were sold at an average price of $20.06, for a transaction totalling $78,234.00. Following the completion of the sale, the president now directly owns 1,211,365 shares of the company's stock, valued at $24,299,981.90. Learn More on Juan C. Jaen's trading history.
Who are Arcus Biosciences' active insiders?: Arcus Biosciences' insider roster includes Robert Goeltz II (CFO), Juan Jaen (President), Jennifer Jarrett (COO), Terry Rosen (CEO), and Carolyn Tang (General Counsel). Learn More on Arcus Biosciences' active insiders.
Are insiders buying or selling shares of Arcus Biosciences?: During the last twelve months, Arcus Biosciences insiders bought shares 1 times. They purchased a total of 15,238,095 shares worth more than $319,999,995.00. During the last twelve months, insiders at the sold shares 7 times. They sold a total of 83,955 shares worth more than $1,577,199.69. The most recent insider tranaction occured on March, 27th when COO Jennifer Jarrett sold 11,551 shares worth more than $202,720.05. Insiders at Arcus Biosciences own 12.3% of the company. Learn More about insider trades at Arcus Biosciences.
Information on this page was last updated on 3/27/2024.

Juan C. Jaen Insider Trading History at Arcus Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/26/2024	Sell	3,900	$20.06	$78,234.00	1,211,365
1/2/2024	Sell	6,975	$20.09	$140,127.75	1,215,265
12/16/2022	Sell	4,436	$30.75	$136,407.00	218,258
6/16/2022	Sell	2,333	$20.72	$48,339.76	212,574
12/16/2021	Sell	865	$39.82	$34,444.30
6/28/2019	Buy	15,000	$7.59	$113,850.00
6/3/2019	Buy	10,000	$8.25	$82,500.00
11/13/2018	Buy	10,000	$11.80	$118,000.00
8/13/2018	Buy	10,000	$11.88	$118,800.00

Juan C. Jaen Buying and Selling Activity at Arcus Biosciences

Arcus Biosciences Company Overview

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's pipeline products include Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial; and AB308, an investigational anti-TIGIT monoclonal antibody, which is in Phase 1b clinical trial to study people with advanced solid and hematologic malignancies. It also develops Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in Phase 2 clinical trial; Quemliclustat, a small-molecule CD73 inhibitor, which is Phase 1b and Phase 2 clinical trial; Zimberelimab, an anti-PD-1 antibody, which is in Phase 2 clinical trial for metastatic cell lung cancer and monotherapy; and AB521, an oral and small-molecule inhibitor of HIF-2a, which is in Phase 1 clinical trial for the treatment of Von Hippel-Lindau disease. In addition, the company's preclinical pipeline products include AB598, a CD39 antibody; and AB801, a small molecule Axl inhibitor. It has a clinical collaboration with AstraZeneca to evaluate domvanalimab in combination with durvalumab in a registrational phase 3 clinical trial in patients with unresectable Stage 3 NSCLC; and BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases. Arcus Biosciences, Inc. was incorporated in 2015 and is headquartered in Hayward, California.

Today's Range

Now: $14.70

$14.20

$15.07

50 Day Range

MA: $16.36

$14.30

$18.44

2 Week Range

Now: $14.70

$13.49

$20.31

Volume

534,476 shs

Average Volume

788,277 shs

Market Capitalization

$1.35 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.89

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

Juan Jaen Biography and Net Worth

What is Juan C. Jaen's net worth?

How old is Juan C. Jaen?

What is Juan C. Jaen's salary?

How do I contact Juan C. Jaen?

Has Juan C. Jaen been buying or selling shares of Arcus Biosciences?

Who are Arcus Biosciences' active insiders?

Are insiders buying or selling shares of Arcus Biosciences?